<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0025">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>WJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wong</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tan</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gao</surname>
    <given-names>GF</given-names>
   </name>
  </person-group>
  <article-title>T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV</article-title>. 
  <source>Antiviral Res</source>. 
  <year>2017</year>;
  <volume>137</volume>:
  <fpage>82</fpage>â€“
  <lpage>92</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.006</pub-id>.
  <pub-id pub-id-type="pmid">27840203</pub-id>
 </mixed-citation>
</ref>
